skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover Nome da Publicação: Journal Of Hematology And Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Yuan, Ruirong ; Kay, Andrea ; Berg, William J ; Lebwohl, David

Journal of hematology and oncology, 2009-10, Vol.2 (1), p.45-45, Article 45 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML
Material Type:
Artigo 		Adicionar ao Meu Espaço

Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML

Cortes, Jorge E ; Lin, Tara L ; Uy, Geoffrey L ; Ryan, Robert J ; Faderl, Stefan ; Lancet, Jeffrey E

Journal of hematology and oncology, 2021-07, Vol.14 (1), p.1-110, Article 110 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia

Alachkar, Houda ; Santhanam, Ramasamy ; Harb, Jason G ; Lucas, David M ; Oaks, Joshua J ; Hickey, Christopher J ; Pan, Li ; Kinghorn, A Douglas ; Caligiuri, Michael A ; Perrotti, Danilo ; Byrd, John C ; Garzon, Ramiro ; Grever, Michael R ; Marcucci, Guido

Journal of hematology and oncology, 2013-03, Vol.6 (1), p.21-21, Article 21 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

Niewerth, Denise ; Kaspers, Gertjan J L ; Jansen, Gerrit ; van Meerloo, Johan ; Zweegman, Sonja ; Jenkins, Gaye ; Whitlock, James A ; Hunger, Stephen P ; Lu, Xiaomin ; Alonzo, Todd A ; van de Ven, Peter M ; Horton, Terzah M ; Cloos, Jacqueline

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.82-82, Article 82 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Emerging therapies for acute myeloid leukemia
Emerging therapies for acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Emerging therapies for acute myeloid leukemia

Saygin, Caner ; Carraway, Hetty E

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.93-93, Article 93 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
6
Precision therapy for acute myeloid leukemia
Precision therapy for acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Precision therapy for acute myeloid leukemia

Yang, Xue ; Wang, Jianxiang

Journal of hematology and oncology, 2018-01, Vol.11 (1), p.3-3, Article 3 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies

Lamers-Kok, Nina ; Panella, Denise ; Georgoudaki, Anna-Maria ; Liu, Haiping ; Özkazanc, Didem ; Kučerová, Lucia ; Duru, Adil Doganay ; Spanholtz, Jan ; Raimo, Monica

Journal of hematology and oncology, 2022-11, Vol.15 (1), p.1-164, Article 164 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Novel and emerging therapies for B cell lymphoma
Novel and emerging therapies for B cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel and emerging therapies for B cell lymphoma

Ayyappan, Sabarish ; Maddocks, Kami

Journal of hematology and oncology, 2019-07, Vol.12 (1), p.82-82, Article 82 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
Signal transduction inhibitors in treatment of myelodysplastic syndromes
Signal transduction inhibitors in treatment of myelodysplastic syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Signal transduction inhibitors in treatment of myelodysplastic syndromes

Bachegowda, Lohith ; Gligich, Oleg ; Mantzaris, Ionnis ; Schinke, Carolina ; Wyville, Dale ; Carrillo, Tatiana ; Braunschweig, Ira ; Steidl, Ulrich ; Verma, Amit

Journal of hematology and oncology, 2013-07, Vol.6 (1), p.50-50, Article 50 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Material Type:
Artigo 		Adicionar ao Meu Espaço

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

Sun, Weili ; Liu, Huaying ; Kim, Young ; Karras, Nicole ; Pawlowska, Anna ; Toomey, Debbie ; Kyono, Wade ; Gaynon, Paul ; Rosenthal, Joseph ; Stein, Anthony

Journal of hematology and oncology, 2018-05, Vol.11 (1), p.61-5, Article 61 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Humans  (20)
  2. Cancer  (15)
  3. Care And Treatment  (14)
  4. Review  (14)
  5. Health Aspects  (14)
  6. Leukemia  (12)
  7. Apoptosis  (8)
  8. Chemotherapy  (8)
  9. Acute Myeloid Leukemia  (8)
  10. Genetic Aspects  (8)
  11. Proteins  (8)
  12. Kinases  (7)
  13. Animals  (6)
  14. Female  (6)
  15. Clinical Trials  (6)
  16. Male  (6)
  17. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2009  (2)
  2. 2009Até2011  (4)
  3. 2012Até2015  (8)
  4. 2016Até2018  (5)
  5. Após 2018  (8)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.